Artwork for podcast Lung Cancer Update
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Episode 31 • 14th September 2025 • Lung Cancer Update • Dr. Neil Love
00:00:00 00:23:19

Share Episode

Shownotes

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. 

CME information and select publications here.

Follow

Links

Chapters

Video

More from YouTube